| Accession Number | 0001193125-26-206273 |
|---|---|
| Form Type | 4 |
| Filing Date | May 5, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Exercise/Conversion | 14,166 | $2.59 | $36,689.94 | 80,249 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 14,023 | $30.16 | $422,985.57 | 66,226 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 1, 2026 | Sale | 143 | $31.00 | $4,433.00 | 66,083 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 1, 2026 | Exercise/Conversion | 14,023 | $0.00 | $0.00 | 205,451 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 1, 2026 | Exercise/Conversion | 143 | $0.00 | $0.00 | 205,308 | Direct | โ | View Details |